Brucellosis and tuberculosis: Clinical overlap and pitfalls
Open Access
- 1 October 2013
- journal article
- Published by Medknow in Asian Pacific Journal of Tropical Medicine
- Vol. 6 (10), 823-825
- https://doi.org/10.1016/s1995-7645(13)60145-5
Abstract
ObjectiveTo identify characteristic features of tuberculosis in patients with culture proven brucellosis.MethodsA retrospective analysis was performed on patients diagnosed with culture proven brucellosis between January and December 2011, based on review of their medical records. Patients with demonstrable co-infection with tuberculosis were excluded. Clinical features, laboratory parameters and tissue histopathology reports where available were noted.ResultsThirty-two patients with brucellosis were included in the study. Twenty-one (65.63%) patients had chronic fever, thirteen (40.63%) had a productive cough, while significant weight loss, evening rise of temperature and night sweats were reported by eight (25.00%), eleven (34.38%) and five (15.63%) patients respectively. Nine (28.13%) patients had at least three of these symptoms. Lymphadenopathy, hepatomegaly and splenomegaly were noted on examination in seven (21.88%), fifteen (46.88%) and twelve (37.50%) patients respectively. Eight (25.00%) patients had hepato-splenomegaly, of these only two had associated significant lymphadenopathy. Respiratory examination was normal in all patients. Elevated ESR greater than 50 mm/hr was seen in eight (25.00%), it was greater than 100 mm/hr in five (15.63%) patients. Hypergammaglobulinemia was seen in eight (25.00%) cases. Bone marrow biopsy showed non-caseating granulomas in three (9.38%) cases, lymph node biopsy showed granulomas in one case. Overall, three (9.38%) patients had known risk factors for tuberculosis, while six (18.75%) had risk factors for brucellosis.ConclusionsThere is a clear overlap between brucellosis and tuberculosis both in terms of clinical presentation and laboratory parameters. It is essential to carefully rule out tuberculosis in all cases of suspected or proven brucellosis before initiating antimicrobial therapy, in order to forestall development of drug-resistant tuberculosisKeywords
This publication has 11 references indexed in Scilit:
- Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosisThe Lancet, 2010
- Human brucellosisThe Lancet Infectious Diseases, 2007
- Evolution of the Extensively Drug-Resistant F15/LAM4/KZN Strain of Mycobacterium tuberculosis in KwaZulu-Natal, South AfricaClinical Infectious Diseases, 2007
- Efficacy of Gentamicin plus Doxycycline versus Streptomycin plus Doxycycline in the Treatment of Brucellosis in HumansClinical Infectious Diseases, 2006
- Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647]BMC Infectious Diseases, 2006
- The new global map of human brucellosisThe Lancet Infectious Diseases, 2006
- Evaluation of the PANBIO Brucella Immunoglobulin G (IgG) and IgM Enzyme-Linked Immunosorbent Assays for Diagnosis of Human BrucellosisClinical and Vaccine Immunology, 2005
- BrucellosisThe New England Journal of Medicine, 2005
- From the discovery of the Malta fever?s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosisVeterinary Research, 2005
- Genetic Polymorphism inMycobacterium tuberculosisIsolates from Patients with Chronic Multidrug‐Resistant TuberculosisThe Journal of Infectious Diseases, 2004